everolimus,sacituzumab govitecan
gilead sciences
['everest', 'tropics02', 'breast', 'trodelvy', '#gi', 'gilead']
#everestmedicines licensing partner #gileadsciences announces positive results from phase 3 #tropics02 study of #trodelvy in heavily pre-treated #hrpositive #her2negative #metastatic #breastcancer patients #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.